Organization
Dept. of Medicinal Chemistry, BMC, Uppsala, Sweden
1 abstract
Abstract
AMAP102, AN ORALLY AVAILABLE 5-HT2 RECEPTOR ANTAGONIST DEVELOPED FOR THE TREATMENT OF RA, IS SAFE AND WELL TOLERATED IN HEALTHY SUBJECTS Org: AnaMar AB, Lund, Acure Pharma AB, Dept. of Medicinal Chemistry, BMC, Uppsala, Sweden,